gilead glp 1 Sciences describes new GLP-1R agonists Gilead Sciences wins U.S. approval
Description
Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A
Treatment plans prioritize safety, realistic results, and long-term success rather than quick fixes
10.3389/fcvm.2023.1278795 [DOI] [PMC free article] [PubMed] [Google Scholar] 79.Maier JA, et al
Most clinical reviews are written for other researchers
